News
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
23h
MedPage Today on MSNSwitching ART Regimens Didn't Lead to Weight Loss in Patients With HIV and ObesityA dults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer ...
A recent episode of the Club 520 podcast featuring Jeff Teague and co-host Bishop B. Henn, real name Brian Hennessy, has ...
Explore more
A major HIV drug maker will return $202 million nationwide after a multi-year investigation and settlement. Pharmaceutical ...
5h
The World from PRX on MSNPEPFAR and the future of the global fight against HIVPEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...
According to the ESSJ, the national treatment cascade, as at last December, shows that 90.0 per cent of all persons living ...
The Punch on MSN6h
Jigawa to roll out HIV drugs at PHCsThe Jigawa State Agency for the Control of AIDS has announced plans to begin dispensing anti-retroviral drugs at primary ...
A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results